165 related articles for article (PubMed ID: 34617209)
1. Positive experiences of healthcare professionals with a mainstreaming approach of germline genetic testing for women with ovarian cancer.
Bokkers K; Zweemer RP; Koudijs MJ; Stehouwer S; Velthuizen ME; Bleiker EMA; Ausems MGEM
Fam Cancer; 2022 Jul; 21(3):295-304. PubMed ID: 34617209
[TBL] [Abstract][Full Text] [Related]
2. The development and evaluation of a nationwide training program for oncology health professionals in the provision of genetic testing for ovarian cancer patients.
Gleeson M; Kentwell M; Meiser B; Do J; Nevin S; Taylor N; Barlow-Stewart K; Kirk J; James P; Scott CL; Williams R; Gamet K; Burke J; Murphy M; Antill YC; Pearn A; Pachter N; Ebzery C; Poplawski N; Friedlander M; Tucker KM;
Gynecol Oncol; 2020 Aug; 158(2):431-439. PubMed ID: 32451123
[TBL] [Abstract][Full Text] [Related]
3. Surgical Oncologists and Nurses in Breast Cancer Care are Ready to Provide Pre-Test Genetic Counseling.
Bokkers K; Bleiker EMA; Aalfs CM; van Dalen T; Velthuizen ME; Duijveman P; Sijmons RH; Koole W; Schoenmaeckers EJP; Ausems MGEM
Ann Surg Oncol; 2023 Jun; 30(6):3248-3258. PubMed ID: 36853565
[TBL] [Abstract][Full Text] [Related]
4. Pilot study of an online training program to increase genetic literacy and communication skills in oncology healthcare professionals discussing BRCA1/2 genetic testing with breast and ovarian cancer patients.
Meiser B; Woodward P; Gleeson M; Kentwell M; Fan HM; Antill Y; Butow PN; Boyle F; Best M; Taylor N; Bell K; Tucker K
Fam Cancer; 2022 Apr; 21(2):157-166. PubMed ID: 33970363
[TBL] [Abstract][Full Text] [Related]
5. Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study.
Vlaming M; Bleiker EMA; van Oort IM; Kiemeney LALM; Ausems MGEM
BMC Cancer; 2022 Dec; 22(1):1365. PubMed ID: 36581909
[TBL] [Abstract][Full Text] [Related]
6. Mainstream germline genetic testing for patients with epithelial ovarian cancer leads to higher testing rates and a reduction in genetics-related healthcare costs from a healthcare payer perspective.
Bokkers K; Frederix GWJ; Velthuizen ME; van der Aa M; Gerestein CG; van Dorst EBL; Lange JG; Louwers JA; Koole W; Zweemer RP; Ausems MGEM
Gynecol Oncol; 2022 Oct; 167(1):115-122. PubMed ID: 36031452
[TBL] [Abstract][Full Text] [Related]
7. Mainstreaming Genetic Testing for Epithelial Ovarian Cancer by Oncology Providers: A Survey of Current Practice.
Czekalski MA; Huziak RC; Durst AL; Taylor S; Mai PL
JCO Precis Oncol; 2022 Jan; 6():e2100409. PubMed ID: 35025618
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a mainstream genetic testing program for women with ovarian or breast cancer.
Ip E; Young AL; Scheinberg T; Harrison M; Beale P; Goodwin A
Asia Pac J Clin Oncol; 2022 Oct; 18(5):e414-e419. PubMed ID: 35098668
[TBL] [Abstract][Full Text] [Related]
9. Uptake of testing for germline
Stearnes G; Nichols CB; Schofield L; O'Sullivan S; Pachter N; Cohen PA
Int J Gynecol Cancer; 2019 Jul; 29(6):1038-1042. PubMed ID: 31101686
[TBL] [Abstract][Full Text] [Related]
10. Cancer Genetic Counseling and Testing: Perspectives of Epithelial Ovarian Cancer Patients and Gynecologic Oncology Healthcare Providers.
Liang MI; Wong DH; Walsh CS; Farias-Eisner R; Cohen JG
J Genet Couns; 2018 Feb; 27(1):177-186. PubMed ID: 28785836
[TBL] [Abstract][Full Text] [Related]
11. Health care professionals' attitudes towards population-based genetic testing and risk-stratification for ovarian cancer: a cross-sectional survey.
Hann KEJ; Fraser L; Side L; Gessler S; Waller J; Sanderson SC; Freeman M; Jacobs I; Lanceley A;
BMC Womens Health; 2017 Dec; 17(1):132. PubMed ID: 29246147
[TBL] [Abstract][Full Text] [Related]
12. Healthcare professionals' perspectives on implementation of universal tumor DNA testing in ovarian cancer patients: multidisciplinary focus groups.
Witjes VM; Braspenning JCC; Hoogerbrugge N; Smolders YHCM; Hermkens DMA; Mourits MJE; Ligtenberg MJL; Ausems MGEM; de Hullu JA
Fam Cancer; 2023 Jan; 22(1):1-11. PubMed ID: 35570228
[TBL] [Abstract][Full Text] [Related]
13. Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics.
Kentwell M; Dow E; Antill Y; Wrede CD; McNally O; Higgs E; Hamilton A; Ananda S; Lindeman GJ; Scott CL
Gynecol Oncol; 2017 Apr; 145(1):130-136. PubMed ID: 28162234
[TBL] [Abstract][Full Text] [Related]
14.
Piedimonte S; Power J; Foulkes WD; Weber E; Palma L; Schiavi A; Ambrosio E; Konci R; Gilbert L; Jardon K; Baret L; Zeng X
Int J Gynecol Cancer; 2020 Nov; 30(11):1757-1761. PubMed ID: 32759180
[TBL] [Abstract][Full Text] [Related]
15. Impacts on oral health attitude and knowledge after completing a digital training module among Swedish healthcare professionals working with older adults.
Snogren M; Ek K; Browall M; Eriksson I; Lindmark U
BMC Health Serv Res; 2024 Feb; 24(1):174. PubMed ID: 38326878
[TBL] [Abstract][Full Text] [Related]
16. The first Japanese nationwide multicenter study of
Enomoto T; Aoki D; Hattori K; Jinushi M; Kigawa J; Takeshima N; Tsuda H; Watanabe Y; Yoshihara K; Sugiyama T
Int J Gynecol Cancer; 2019 Jul; 29(6):1043-1049. PubMed ID: 31263023
[TBL] [Abstract][Full Text] [Related]
17. An Australian mainstream genetic testing program: Clinicians views about current and future practices.
Young AL; Ip E; Scheinberg T; Harrison M; Beale P; Goodwin A
Asia Pac J Clin Oncol; 2024 Feb; 20(1):119-127. PubMed ID: 37985938
[TBL] [Abstract][Full Text] [Related]
18. Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
Konstantinopoulos PA; Norquist B; Lacchetti C; Armstrong D; Grisham RN; Goodfellow PJ; Kohn EC; Levine DA; Liu JF; Lu KH; Sparacio D; Annunziata CM
J Clin Oncol; 2020 Apr; 38(11):1222-1245. PubMed ID: 31986064
[TBL] [Abstract][Full Text] [Related]
19. The integration of BRCA testing into oncology clinics.
Percival N; George A; Gyertson J; Hamill M; Fernandes A; Davies E; Rahman N; Banerjee S
Br J Nurs; 2016 Jun; 25(12):690-4. PubMed ID: 27345073
[TBL] [Abstract][Full Text] [Related]
20. Mainstream genetic testing for women with ovarian cancer provides a solid basis for patients to make a well-informed decision about genetic testing.
Bokkers K; Bleiker EMA; Hoogendam JP; Velthuizen ME; Schreuder HWR; Gerestein CG; Lange JG; Louwers JA; Koudijs MJ; Ausems MGEM; Zweemer RP
Hered Cancer Clin Pract; 2022 Sep; 20(1):33. PubMed ID: 36076240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
